Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J BARNETT

Showing results (771-780 of 838) with videos related to

Pageof 84
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care CenterShruthi Ganeshappa Kodad, Heather Sutherland, Wasithep Limvorapitak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myelomaJohn Kuruvilla, John D Shepherd, Heather J Sutherland, et al.
Bone Marrow Transplantation|August 28, 1998
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantationD R Simpson, T J Nevill, J D Shepherd, et al.
Bone Marrow Transplantation|March 29, 2000
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemiaC L Toze, J D Shepherd, J M Connors, et al.
BMC Public Health|March 9, 2012
Determinants of emergency response willingness in the local public health workforce by jurisdictional and scenario patterns: a cross-sectional surveyDaniel J Barnett, Carol B Thompson, Nicole A Errett, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Bone Marrow Transplantation|November 3, 2010
Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort studyM D Seftel, K Paulson, R Doocey, et al.
Pageof 84

Showing results (771-780 of 838) with videos related to

Sort By:
Pageof 84
Clinical Lymphoma, Myeloma & Leukemia|November 4, 2019
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care CenterShruthi Ganeshappa Kodad, Heather Sutherland, Wasithep Limvorapitak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myelomaJohn Kuruvilla, John D Shepherd, Heather J Sutherland, et al.
Bone Marrow Transplantation|August 28, 1998
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantationD R Simpson, T J Nevill, J D Shepherd, et al.
Bone Marrow Transplantation|March 29, 2000
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemiaC L Toze, J D Shepherd, J M Connors, et al.
BMC Public Health|March 9, 2012
Determinants of emergency response willingness in the local public health workforce by jurisdictional and scenario patterns: a cross-sectional surveyDaniel J Barnett, Carol B Thompson, Nicole A Errett, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Bone Marrow Transplantation|November 3, 2010
Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort studyM D Seftel, K Paulson, R Doocey, et al.
Pageof 84